Connect with us
In 2024, Novo Nordisk expects its sales to increase between 18% and 26% at constant exchange rates, while it anticipates operating profit growth at constant exchange...
Novo Nordisk has entered independent research collaboration agreements with Omega Therapeutics and Cellarity to develop innovative therapeutic approaches for cardiometabolic diseases, with each company potentially receiving...
The demand for products indicated against diabetes has increased. Large groups in the sector announced new investment plans to grow in this segment. However, not everything...
Novo Nordisk plans a €2.1 billion investment to strengthen its presence in France's industrial sector, according to French President. The biotech company aims to expand the...
More than half of the population of the countries of the Organization for Economic Cooperation and Development (OECD) was overweight or obese, according to the latest...
Novo Nordisk increased its profit by 42.5% in the first half of 2023, reaching 39,242 million Danish crowns (€5.26 million). The firm has decided to increase...
This year, one of the main headaches for managers in the sector will be inflation. GSK and Novartis plan to carry out a double-digit price increase...
Merck MSD acquired Imago BioSciences and expects the deal to close in the first quarter of 2023. Novo Nordisk will invest €726 million (DKK 5.4 billion)...
Currently, in Spain, it is estimated that around 3% of the population under 15 years of age has a short stature that may be related to...
Lars Sørensen's leadership has put Novo Nordisk at the top of its industry.